TMCnet News

Global Antiretroviral Therapy Market - Forecast to Grow at a CAGR of 2.6% During 2017-2021 - Research and Markets

[December 27, 2017]

Global Antiretroviral Therapy Market - Forecast to Grow at a CAGR of 2.6% During 2017-2021 - Research and Markets

The "Global Antiretroviral Therapy Market 2017-2021" report has been added to Research and Markets' offering.

The global antiretroviral therapy market is expected to grow at a CAGR of 2.64% during the period 2017-2021.

The report, Global Antiretroviral Therapy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

The latest trend gaining momentum in the market is the significant pipeline. Several promising antiretroviral agents are in the pipeline, which will boost the market growth in the long run. The approval of new therapeutic agents will broaden the options available for treatment and thus will lead to the increase in demand for therapeutic regimens. There are approximately 37 molecules under different clinical trial stages globally of which 18 molecules are in phaseII, and 13 molecules are in phase-III for various retroviral malignancies. The remaining molecules are in phase-I of their clinical trials.

According to the report, one of the major drivers for this market is the rising awareness of retroviral infection. The awareness about retroviral infection is on the rise. Initiatives such as the Centers for Disease Control and Prevention's (CDC's) Act Against AIDS, targeted to make the youth aware of the risk of HIV infection because of concurrent use of alcohol and drugs, will drive the growth of the market. The initiatives by various governments also help to create awareness.

Key vendors